Literature DB >> 28910792

Inflammation: A Key Contributor to the Genesis and Progression of Chronic Kidney Disease.

Qi Qian1.   

Abstract

It has become apparent that inflammation and inflammatory reactions can evoke renal injury and promote chronic kidney disease (CKD) progression. Under physiological condition, intrarenal vascular distribution is heterogeneous, and medulla is hypoxic. To avoid energy deprivation in the low pO2 regions of the kidney, an array of hormones, autocoids, and vasoactive substances, including medullipin, prostaglandins, endothelins, nitric oxide, angiotensin II, kinins, and adenosine, tonically regulates the microvasculature to ensure a perfect match of the microcirculation (O2 supply) and renal tubules (O2 demand). Inflammation, systemic or intrarenal, not only can abolish the microvascular response to its regulators, but also induces an array of tubular toxins, including reactive oxygen species, leading to tubular injury, nephron dropout, and onset of CKD. Positive acid balance, electrolyte alterations, and intestinal dysbiosis can perpetuate CKD progression. Understanding the role of inflammation in the genesis and progression of CKD will foster the development of strategies to prevent and treat the underlying inflammation and improve CKD outcomes.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28910792     DOI: 10.1159/000479257

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  14 in total

Review 1.  Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.

Authors:  Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2020-02-17       Impact factor: 3.657

Review 2.  Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2018-04-20       Impact factor: 5.717

Review 3.  Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Lucian Albulescu; Laura Georgiana Necula; Cristina Mambet; Gabriela Anton; Cristiana Tanase
Journal:  J Immunol Res       Date:  2018-09-06       Impact factor: 4.818

4.  Dietary Influence on Body Fluid Acid-Base and Volume Balance: The Deleterious "Norm" Furthers and Cloaks Subclinical Pathophysiology.

Authors:  Qi Qian
Journal:  Nutrients       Date:  2018-06-16       Impact factor: 5.717

Review 5.  Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.

Authors:  Hyung Muk Choi; Hari Madhuri Doss; Kyoung Soo Kim
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

6.  Renalase in Haemodialysis Patients with Chronic Kidney Disease.

Authors:  Magda Wisniewska; Natalia Serwin; Violetta Dziedziejko; Małgorzata Marchelek-Mysliwiec; Barbara Dołegowska; Leszek Domanski; Kazimierz Ciechanowski; Krzysztof Safranow; Andrzej Pawlik
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

7.  A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model.

Authors:  Xinyi Yu; Yunfeng Xia; Liyi Zeng; Xi Zhang; Liqun Chen; Shujuan Yan; Ruyi Zhang; Chen Zhao; Zongyue Zeng; Yi Shu; Shifeng Huang; Jiayan Lei; Chengfu Yuan; Linghuan Zhang; Yixiao Feng; Wei Liu; Bo Huang; Bo Zhang; Wenping Luo; Xi Wang; Hongmei Zhang; Rex C Haydon; Hue H Luu; Tong-Chuan He; Hua Gan
Journal:  Sci Rep       Date:  2018-07-20       Impact factor: 4.379

Review 8.  Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites.

Authors:  Shara Francesca Rapa; Biagio Raffaele Di Iorio; Pietro Campiglia; August Heidland; Stefania Marzocco
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

9.  Essential amino acid supplementation is associated with reduced serum C-reactive protein levels and improved circulating lymphocytes in post-acute inflamed elderly patients.

Authors:  Roberto Aquilani; Ginetto C Zuccarelli; Roberto Maestri; Mirella Boselli; Maurizia Dossena; Eleonora Baldissarro; Federica Boschi; Daniela Buonocore; Manuela Verri
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

10.  Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study.

Authors:  Mohsen Mazidi; Richard J Webb; Gregory Y H Lip; Andre P Kengne; Maciej Banach; Ian G Davies
Journal:  J Clin Med       Date:  2022-01-09       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.